Novartis

Novartis Pharma Ex-CEO takes three roles in two days
Pharmafile
Sat, 01/6/18 - 12:36 pm
Novartis
Pharma CEOs
David Epstein
Axcella Health
Rubius
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
cancer
Merck
Japan
Keytruda
Seattle Genetics
Adcetris
Novartis
Kisqali
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Fierce Pharma
Thu, 01/4/18 - 10:27 pm
drug pricing
Pfizer
Novartis
AbbVie
Novartis Gets Second Breakthrough Designation for Kisqali
Yahoo/Zacks.com
Thu, 01/4/18 - 09:50 pm
Novartis
Kisqali
breast cancer
Top 10 stories that had pharma execs talking
Biopharma Dive
Thu, 01/4/18 - 12:02 pm
M&A
Bristol-Myers Squibb
Opdivo
Express Scripts
Novartis
C-ART
Kymriah
Massachusetts
AbbVie
Kenneth Frazier
biosimilars
CVS Health Pfizer
Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels
RAPS.org
Sat, 12/23/17 - 11:58 am
Novartis
generics
California
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Endpoints
Thu, 12/21/17 - 10:12 am
Kymriah
Yescarta
CAR-T
Novartis
Kite Pharma
Gilead Sciences
drug pricing
P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
Fierce Pharma
Tue, 12/19/17 - 10:20 am
P&G
Novartis
Pharma CEOs
Joe Jimenez
What’s the big hurry Novartis? Pharma giant scores a PRV shortcut for $130M
Endpoints
Mon, 12/18/17 - 10:02 am
Novartis
priority review vouchers
Ultragenyx
Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval
Fierce Pharma
Fri, 12/15/17 - 11:27 pm
Pfizer
Novartis
Eli Lilly
Xeljanz
psoriatic arthritis
Novartis oncology CEO Bruno Strigini is calling it quits
Endpoints
Fri, 12/15/17 - 10:09 am
Novartis
oncology
Bruno Strigini
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
ASH17
Biomarin
Spark Therapeutics
Gilead Sciences
Novartis
Juno Therapeutics
AbbVie
Roche
JNJ
ASH 2017: CAR-T Wallops Blood Cancer
Motley Fool
Tue, 12/12/17 - 11:16 am
ASH2017
CAR-T
gene therapy
Novartis
Kymriah
Yescarta
Gilead Sciences
Juno Therapeutics
JCAR017
#ASH17: How does Novartis’ Kymriah DLBCL data stack up heading straight to a CAR-T showdown with Gilead?
Endpoints
Sun, 12/10/17 - 11:10 am
ASH17
Novartis
Kymriah
DLBCL
CAR-T
diffuse large B-cell lymphoma
NICE nods for AbbVie in hep C and Novartis in lung cancer
Pharma Times
Sun, 12/10/17 - 09:53 am
NICE
AbbVie
hepatitis C
Maviret
Novartis
Zykadia
ALK-positive non-small cell lung cancer
Novartis seeks to revive Neulasta biosim prospects with data showing it matches Amgen’s blockbuster
Fierce Pharma
Fri, 12/8/17 - 10:41 am
Novartis
Neulasta
biosimilars
Amgen
Sandoz
FDA
Roche, Novartis' Italian heads risk trial for alleged market rigging: sources
Yahoo/Reuters
Fri, 12/8/17 - 10:00 am
Roche
Novartis
Italy
Avastin
Lucentis
marketing manipulation
In Young Women, Kisqali Slows Metastatic Breast Cancer And Relieves Symptoms
Forbes
Thu, 12/7/17 - 09:10 am
Novartis
Kisqali
metastatic breast cancer
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Fierce Pharma
Tue, 12/5/17 - 09:30 am
Eli Lilly
Taltz
Novartis
Cosentyx
FDA
psoriatic arthritis
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Fierce Pharma
Mon, 12/4/17 - 11:39 am
Novartis
generics
Sandoz
M&A

Pages